Optimal healing and DAPT duration in today’s complex PCI: the Synergy stent

Chairperson: Ian T. MEREDITH


To learn how the Synergy stent is being used in complex patient subsets
To learn how durable and bioabsorbable polymers and stent design impact both early and late healing
To understand the current evidence when assessing ischaemic, bleeding and thrombotic risks for specific patient subsets


Session objectives

I. Meredith

PCI in elderly patients: device and pharmacotherapy considerations in next generation DES

T. Cuisset

Early healing with Synergy in real-world patients

J.M. De La Torre Hernandez

Optimal revascularisation in multivessel disease and coronary CTO: the Belfast experience

S. Walsh

Synergy in an all-comer population: the SWEET registry

S. Cook

Session evaluation and key learnings

K.G. Oldroyd


More from Boston Scientific

The Lotus valve: advancing treatment options for patients with challenging anatomies

Chairperson: Ted Feldman

Left atrial appendage closure: which patients benefit most?

Chairperson: Maurice BUCHBINDER, Alec VAHANIAN
Visit website